跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LINAGLIPTINA KRKA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LINAGLIPTINA KRKA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LINAGLIPTINA KRKA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 18, 2025
Approval ID
7bbaf0e297caa2d0
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
7bbaf0e297caa2d0
Drug Cima Aemps Name
LINAGLIPTINA KRKA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90563
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2025-09-18
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 18, 2025
Approval ID
7bbaf0e297caa2d0
Type
Standard
Back to CIMA-AEMPS Approvals